Dumont & Blake Investment Advisors LLC reduced its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report) by 1.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 19,355 shares of the company’s stock after selling 188 shares during the period. Dumont & Blake Investment Advisors LLC owned 0.57% of Invesco Pharmaceuticals ETF worth $1,599,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of PJP. Jane Street Group LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth $1,163,000. Envestnet Asset Management Inc. boosted its holdings in shares of Invesco Pharmaceuticals ETF by 87.7% during the 2nd quarter. Envestnet Asset Management Inc. now owns 23,878 shares of the company’s stock worth $1,963,000 after buying an additional 11,156 shares during the period. HBW Advisory Services LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth $509,000. Arete Wealth Advisors LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth $402,000. Finally, Grimes & Company Inc. bought a new stake in shares of Invesco Pharmaceuticals ETF during the 4th quarter worth $354,000.
Invesco Pharmaceuticals ETF Trading Up 0.7 %
NYSEARCA PJP opened at $86.68 on Friday. The company has a market cap of $293.85 million, a P/E ratio of 21.48 and a beta of 0.61. Invesco Pharmaceuticals ETF has a 1 year low of $75.33 and a 1 year high of $89.87. The company has a fifty day simple moving average of $84.37 and a 200 day simple moving average of $85.73.
Invesco Pharmaceuticals ETF Company Profile
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Recommended Stories
- Five stocks we like better than Invesco Pharmaceuticals ETF
- What Are Dividends? Buy the Best Dividend Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Technology Stocks Explained: Here’s What to Know About Tech
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report).
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
